Dietary components of bitter leaf is a promising inhibitor of COVID-19
Dietary components from bitter leaf as promising inhibitors of COVID-19 The coronavirus disease 19 (COVID-19) is caused by the virus severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), which has affected million's of individuals with its adverse effects on national economies, public health, educational system, and social life. Our studies have suggested promising inhibitors of SARS-CoV-2 replication and infectivity from bitter leaf a West African culinary plant. These potential nutraceutical include: Vernonioside A2 Vernonioside D2 Vernonioside A4 Vernoniamyoside C Vernomygdin Vernonioside B2 Click here to read more: Dietary stigmastane-type saponins as promising dual-target directed inhibitors of SARS-CoV-2 proteases: a structure-based screening - RSC Advances (RSC Publishing)